82% of Physicians Are Employed, and Your Deal May Rest on One Veto

Enterprise healthcare deals now involve six to 10 decision-makers across clinical, financial, IT and operational functions, and they run on 12- to 24-month cycles. Roughly 82 percent of physicians now work for a hospital, health system or corporate entity rather than an independent practice, according to the Physicians Advocacy Institute's Avalere Health report on employment trends from 2018 through 2026. When providers sit inside a centralized organization, buying authority moves up and away from the clinic where the rep first shook hands.

The stakeholder most likely to kill the deal is the clinical leader: the chief medical officer, the lead physician, or the provider who runs the practice. They may never touch the product. Sellers assume that means they need no selling. It does not.

Why the clinical leader holds the real veto

The author, a veteran of pharma and medical device diagnostics sales who now sells revenue technology to healthcare organizations, recounts a physician so opposed to switching electronic health records that the change drove them to retire rather than adopt the new system. Nobody asked whether they wanted the software. The objection surfaced too late to save the relationship.

That is the clinical veto. It rarely appears on a stakeholder map. By the time it does, the deal is usually already gone.

Why do healthcare titles mislead sellers?

In most industries the Chief Revenue Officer is the prime target. In healthcare, that title frequently covers claims and insurance reimbursement, including what pays best and what is on Formulary, which makes the holder closer to an accountant than a buyer. Anchor a deal on that title and the effort lands on someone with limited authority over the purchase.

A better lens: follow how the organization makes money — seeing patients, billing insurance, running procedures — and map power from there. The roles that genuinely matter:

• The care provider, often a physician or chief medical officer, who has a say in nearly everything.
• Commercial operations, which govern day-to-day running of the business.
• The VP of business development, who owns growth priorities.
• Emerging roles such as chief AI officers and directors, who increasingly weigh in on technology decisions.

The critical buyer may also be a VP of ambulatory operations or a corporate medical director overseeing standardization across five to 200-plus sites, not the administrator at the first location visited. Reps can run a flawless process at one clinic and stay invisible to the person who signs for the whole network.

How do you find the stakeholders you missed?

Hidden detractors kill more deals than tough negotiators. It might be a physician with informal pull, or a supply-chain and procurement function that can overrule even a champion doctor. One unthreaded skeptic near the money can stall everything.

The missing stakeholder is usually already in the account's history. Review past deals and closed-lost opportunities: who was contacted, where the deal stalled, who made the final call. Then re-engage those warm contacts. A key persona the seller never knew existed often sits in a closed-lost record from months ago.

End users matter too. They sell the solution internally once the rep leaves the room, and that internal advocacy is how deals survive long cycles.

Gong positions its Revenue AI as the tool for this: surfacing which personas are engaged and which are not, flagging hidden detractors, and revealing who was contacted in past lost deals so teams can multi-thread before a decision is made without them. The vendor's claim is a product assertion, not an independent benchmark, but the underlying diagnosis — engagement gaps across complex committees — is what its healthcare customers report feeling.

The practical next step needs no software. Take your top three opportunities this week and ask one hard question of each: have you actually threaded the clinical leader, or assumed the economic buyer speaks for them? If the answer is not a name, that is your next call.